Centers for Advanced Diagnostics and Experimental Therapeutics in Lung Diseases Stage II (CADET II)(UH2/UH3)

The summary for the Centers for Advanced Diagnostics and Experimental Therapeutics in Lung Diseases Stage II (CADET II)(UH2/UH3) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Centers for Advanced Diagnostics and Experimental Therapeutics in Lung Diseases Stage II (CADET II)(UH2/UH3): The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for Centers for Advanced Diagnostics and Experimental Therapeutics in Lung Diseases Stage II (CADET II). The goal of the CADET program is to accelerate the development of novel products for the treatment of lung diseases and sleep disordered breathing using strategies based on relevant pathobiologic processes. Whereas the prior funding opportunity, CADET I, provided the opportunity to explore and validate potential therapeutic targets, the current funding opportunity, CADET II, hereafter designated "CADET," will support preclinical research on therapeutic products for which the target has been validated. It is anticipated that CADET projects may vary substantially in their objectives and scope of research.
Federal Grant Title: Centers for Advanced Diagnostics and Experimental Therapeutics in Lung Diseases Stage II (CADET II)(UH2/UH3)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-HL-14-001
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.838
CFDA Descriptions: Lung Diseases Research
Current Application Deadline: Oct 17, 2013
Original Application Deadline: Oct 17, 2013
Posted Date: Jul 17, 2013
Creation Date: Jul 17, 2013
Archive Date: Nov 17, 2013
Total Program Funding: $75,000,000
Maximum Federal Grant Award: $1,000,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Grant Announcement Contact
NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants
Limited Competition: Physician Scientist Transition to Independence in Blood Science Resea...
Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Data Coordi...
Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Human Tissu...
Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Research Centers (U01 Clin...
Pathogenesis of Sars Lung Disease: in Vitro Studies and Animal Models
Lung Response to Inhaled Highly Toxic Chemicals
Protein Interactions Governing Membrane Transport in Pulmonary Health and Disease (R01)
More Grants from the National Institutes of Health
Mechanisms of Reciprocal Interactions between HIV Associated Neuroinflammation and CNS Per...
Summer Research Education Experience Program (R25 Clinical Trial Not Allowed)
Mechanisms of Reciprocal Interactions between HIV Associated Neuroinflammation and CNS Per...
Research Opportunities in Crisis Response Services for Suicide Prevention (R01 Clinical Tr...
Pilot Research Opportunities in Crisis Response Services for Suicide Prevention (R34 Clini...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com